Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. Posted 73.2 Million Yuan Net Loss in 2022

Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co.,Ltd. (杭州天目山药业股份有限公司) (600671.SH) reported a net loss of 73.2 million yuan in 2022, widening 123.3% year-on-year.

Meanwhile, the company posted 108.9 million yuan in revenue, down 25.9% year-on-year.

At the end of the reporting period, it had 299.8 million yuan in total assets and 295.4 million yuan in total liabilities, with a liability-to-asset ratio of 98.5%.